{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:51:49Z","timestamp":1765295509011,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejso.2024.108692","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:33:55Z","timestamp":1726295635000},"page":"108692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study"],"prefix":"10.1016","volume":"50","author":[{"given":"Xin-Li","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Dong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Bao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-6538","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejso.2024.108692_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.6004\/jnccn.2023.7055","article-title":"Principles of surgical management of peritoneal mesothelioma","volume":"21","author":"Steadman","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"19","key":"10.1016\/j.ejso.2024.108692_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194704","article-title":"Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions","volume":"15","author":"Karpes","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108692_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/890450","article-title":"Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous cisplatin for diffuse malignant peritoneal mesothelioma","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.ejso.2024.108692_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.21037\/tlcr.2018.08.03","article-title":"Update on the management of malignant peritoneal mesothelioma","volume":"7","author":"Sugarbaker","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"12","key":"10.1016\/j.ejso.2024.108692_bib5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/17425247.2019.1693997","article-title":"Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them","volume":"16","author":"Sugarbaker","year":"2019","journal-title":"Expet Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.ejso.2024.108692_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005340.pub2","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","author":"Jaaback","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejso.2024.108692_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1078155213506244","article-title":"Intraperitoneal chemotherapy: rationale, applications, and limitations","volume":"20","author":"Al-Quteimat","year":"2014","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.ejso.2024.108692_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00686048","article-title":"Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment","volume":"25","author":"Los","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejso.2024.108692_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2024.108692_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108692_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1634\/theoncologist.10-2-112","article-title":"Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy","volume":"10","author":"Sugarbaker","year":"2005","journal-title":"Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108692_bib12","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","article-title":"Peritoneal mesothelioma","volume":"9","author":"Greenbaum","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejso.2024.108692_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/752643","article-title":"Adjuvant bidirectional chemotherapy using an intraperitoneal port","volume":"2012","author":"Sugarbaker","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.ejso.2024.108692_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1245\/s10434-006-9187-5","article-title":"Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108692_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.21037\/tlcr.2018.10.04","article-title":"Malignant peritoneal mesothelioma: a review","volume":"7","author":"Broeckx","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.ejso.2024.108692_bib16","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/archsurg.1990.01410230071012","article-title":"Primary malignant peritoneal mesothelioma. a report of seven cases and a review of the literature","volume":"125","author":"Asensio","year":"1990","journal-title":"Arch Surg"},{"issue":"Suppl 10","key":"10.1016\/j.ejso.2024.108692_bib17","doi-asserted-by":"crossref","first-page":"x241","DOI":"10.1093\/annonc\/mdl267","article-title":"Intraperitoneal chemotherapy in advanced ovarian cancer: recognition at last","volume":"17","author":"Vermorken","year":"2006","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108692_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11864-002-0003-6","article-title":"Peritoneal mesothelioma","volume":"3","author":"Mohamed","year":"2002","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108692_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","article-title":"Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival","volume":"43","author":"Sugarbaker","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108692_bib20","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1245\/s10434-019-08139-4","article-title":"Two-stage cytoreductive surgery and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: predictors of overall survival in an intention-to-treat series","volume":"27","author":"Leinwand","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108692_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","article-title":"Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence","volume":"7","author":"Ceelen","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108692_bib22","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1245\/s10434-021-10048-4","article-title":"Cytoreductive urgery plus HIPEC with and without NIPEC for malignant peritoneal mesothelioma: a propensity-matched analysis","volume":"28","author":"Sugarbaker","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108692_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3835(90)90045-Y","article-title":"The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat","volume":"51","author":"Los","year":"1990","journal-title":"Cancer Lett"},{"issue":"36","key":"10.1016\/j.ejso.2024.108692_bib24","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108692_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ejso.2024.108692_bib26","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1245\/s10434-022-13061-3","article-title":"Long-term survival in patients treated with cytoreduction and heated intraperitoneal chemotherapy for peritoneal mesothelioma at a single high-volume center","volume":"30","author":"Valenzuela","year":"2023","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324007443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324007443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T13:39:11Z","timestamp":1730468351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324007443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0748798324007443"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108692","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108692"}}